Nice to see Pato's are fully underwriting the rights issue ... plus Mansour is partially sub-underwriting the issue.
Nice tick of approval for PeriCoach.
The value proposition is simple (as stated in today's release) - $600 on incontinence pads p.a. (a real and on-going expense) that only treats the symptoms vs half that for PeriCoach with the potential to provide a cure.
Seems a no brainer to me. Also always nice when the cap raising comes in near your buy in price!
Nice to see Pato's are fully underwriting the rights issue ......
Add to My Watchlist
What is My Watchlist?